141 related articles for article (PubMed ID: 38102975)
1. Modifiable prognostic factors in uterine fibroid development: a systematic review of literature.
Keizer AL; Semmler A; Kok HS; van Kesteren PJM; Huirne JAF; Hehenkamp WJK
J Obstet Gynaecol; 2024 Dec; 44(1):2288225. PubMed ID: 38102975
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
3. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
4. Uterine fibroids and cardiovascular risk.
Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.
Combs A; Singh B; Nylander E; Islam MS; Nguyen HV; Parra E; Bello A; Segars J
Reprod Sci; 2023 Apr; 30(4):1049-1064. PubMed ID: 35960442
[TBL] [Abstract][Full Text] [Related]
6. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
7. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
Vitagliano A; Noventa M; Di Spiezio Sardo A; Saccone G; Gizzo S; Borgato S; Vitale SG; Laganà AS; Nardelli GB; Litta PS; Saccardi C
Arch Gynecol Obstet; 2018 Apr; 297(4):823-835. PubMed ID: 29236171
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 25-hydroxy vitamin D3 levels in patients with a fibroid uterus.
Srivastava P; Gupta HP; Singhi S; Khanduri S; Rathore B
J Obstet Gynaecol; 2020 Jul; 40(5):710-714. PubMed ID: 31635506
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
12. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. African genetic ancestry interacts with body mass index to modify risk for uterine fibroids.
Giri A; Edwards TL; Hartmann KE; Torstenson ES; Wellons M; Schreiner PJ; Velez Edwards DR
PLoS Genet; 2017 Jul; 13(7):e1006871. PubMed ID: 28715450
[TBL] [Abstract][Full Text] [Related]
15. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions.
Taheri M; Galo L; Potts C; Sakhel K; Quinn SD
Int J Hyperthermia; 2019; 36(1):295-301. PubMed ID: 30676099
[TBL] [Abstract][Full Text] [Related]
16. Intra-abdominal haemorrhage from uterine fibroids: a systematic review of the literature.
Lim WH; Cohen SC; Lamaro VP
BMC Surg; 2020 Apr; 20(1):70. PubMed ID: 32293414
[TBL] [Abstract][Full Text] [Related]
17. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
18. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic Fibroid Management: Systematic Review of the Literature.
Havryliuk Y; Setton R; Carlow JJ; Shaktman BD
JSLS; 2017; 21(3):. PubMed ID: 28951653
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding.
Zhang J; Go VA; Blanck JF; Singh B
Reprod Sci; 2022 Oct; 29(10):2786-2809. PubMed ID: 34480321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
